Bionoid Pharma, Inc. (BINP) Stock Analysis
DELISTED 2025
What happened to Bionoid Pharma, Inc. (BINP) stock?
Bionoid Pharma, Inc. (BINP) no longer trades on public markets. It was delisted in December 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- December 2025
- Last recorded price (historical):
- $0.03 (last quote on record before the December 2025 delisting; historical, not a current quote)
Market cap $1.62M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Bionoid Pharma, Inc. (BINP). Bionoid Pharma, Inc. is a medical device company focused on developing and marketing innovative technologies for the orthopedic and pain management markets. The company operates on the OTC market, presenting unique investment considerations.
Last analyzed: Mar 18, 2026Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
Bionoid Pharma, Inc. (BINP) Healthcare & Pipeline Overview
BINP OTC Market Information
BINP trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy BINP shares?
No. BINP stopped trading on public markets in December 2025, so the shares are not available through a broker. Anything you see quoted for BINP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BINP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Bionoid Pharma, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.